TPP Alberta update: PrescribeIT and Type 1 prescribing requirements

Read time: 1 minute

In September 2020, the TPP Alberta Steering Committee approved the use of PrescribeIT for methadone prescribing, waiving the previous requirement for a TPP secure prescription form.

At their May 4, 2023, meeting, the TPP Steering Committee will consider a request from Canada Health Infoway for a broader exemption from the use of TPP forms, allowing electronic prescribing with PrescribeIT for all type 1 TPP drugs.

Interim exemptions from the use of secure TPP forms for type 1 TPP-monitored drugs is currently permitted if the following conditions are met:

• Both the prescriber and pharmacy are enabled with PrescribeIT and use it for system-to-system communications.
• The patient has a choice of the pharmacy where their prescription(s) is filled and must not be directed only to PrescribeIT-enabled pharmacies.

Alberta prescribers and pharmacies who are already using PrescribeIT for electronic prescribing of TPP type 1 drugs can temporarily continue to do so to minimize risk of interruptions to patient care. Further updates and guidance will be issued following the TPP Steering Committee’s deliberations in May.

Questions? Email TPP.Info@cpsa.ab.ca